![]() Exscientia Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery. | ![]() Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. | ||
Founding Date | Founding Date 2015 | Founding Date 2012 | Founding Date 1982 |
Type | Type Private | Type Subsidiary | Type Subsidiary |
Tags | |||
Locations | Locations Hemel Hempstead, GB HQ | Locations Oxford, GB HQ Wien, AT Osaka, JP Dundee, GB Miami, US | Locations Morris Plains, US HQ |
Employees | Employees 965% decrease | Employees 88 | Employees 8914% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £20.1m (FY, 2023) | Revenue (est.) $295k (FY, 2019) |
Cost of goods | Cost of goods N/A | Cost of goods £10.5m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit £10.8m (FY, 2023) | Gross profit $295k (FY, 2019) |
Net income | Net income N/A | Net income (£146m) (FY, 2023) | Net income ($357.3m) (FY, 2019) |
Funding | |||
Total funding raised | Total funding raised $ 54.2m | Total funding raised $ 430.2m | Total funding raised $ 30m |

Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery.
View company
Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.
View company